EMA Authorised: Zaltrap (aflibercept) — Sanofi Winthrop Industrie

View source ↗

Summary

The European Medicines Agency authorised Zaltrap (aflibercept) for colorectal cancer in the European Union, with Sanofi Winthrop Industrie as the marketing auth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Status: Authorised. Therapeutic area: Colorectal Neoplasms. MAH: Sanofi Winthrop Industrie. Decision date: 27/08/2024